Cite
HARVARD Citation
Paz-Ares, L. et al. (n.d.). LBA3 Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (aNSCLC): CheckMate 227 - part 2 final analysis. Annals of oncology. p. . [Online].